Galectin Therapeutics
GALT
GALT
49 hedge funds and large institutions have $12.5M invested in Galectin Therapeutics in 2017 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 16 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0.61% less ownership
Funds ownership: 11.1% → 10.49% (-0.61%)
56% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 16
Holders
49
Holding in Top 10
–
Calls
$1.34M
Puts
$1.18M
Top Buyers
| 1 | +$214K | |
| 2 | +$171K | |
| 3 | +$161K | |
| 4 |
ARTA
A.R.T. Advisors
New York
|
+$120K |
| 5 |
WS
Wedbush Securities
Los Angeles,
California
|
+$102K |
Top Sellers
| 1 | -$330K | |
| 2 | -$291K | |
| 3 | -$267K | |
| 4 |
BSW
Buckingham Strategic Wealth
Clayton,
Missouri
|
-$132K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$75.6K |